Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

Mental health treatment patterns in perinatally HIV-infected youth and controls.

Chernoff M, Nachman S, Williams P, Brouwers P, Heston J, Hodge J, Di Poalo V, Deygoo NS, Gadow KD; IMPAACT P1055 Study Team.

Pediatrics. 2009 Aug;124(2):627-36. doi: 10.1542/peds.2008-2441. Epub 2009 Jul 13.

2.

Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons.

Gadow KD, Angelidou K, Chernoff M, Williams PL, Heston J, Hodge J, Nachman S.

J Dev Behav Pediatr. 2012 Jul;33(6):456-68. doi: 10.1097/DBP.0b013e31825b8482.

3.

Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households.

Serchuck LK, Williams PL, Nachman S, Gadow KD, Chernoff M, Schwartz L; IMPAACT 1055 Team.

AIDS Care. 2010 May;22(5):640-8. doi: 10.1080/09540120903280919.

4.

Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters.

Mellins CA, Brackis-Cott E, Leu CS, Elkington KS, Dolezal C, Wiznia A, McKay M, Bamji M, Abrams EJ.

J Child Psychol Psychiatry. 2009 Sep;50(9):1131-8. doi: 10.1111/j.1469-7610.2009.02069.x. Epub 2009 Feb 27.

5.

Emotional and behavioral problems and mental health service utilization of youth living with HIV acquired perinatally or later in life.

Marhefka SL, Lyon M, Koenig LJ, Orban L, Stein R, Lewis J, Tepper VJ.

AIDS Care. 2009 Nov;21(11):1447-54. doi: 10.1080/09540120902883085.

PMID:
20024723
6.

Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure.

Malee KM, Tassiopoulos K, Huo Y, Siberry G, Williams PL, Hazra R, Smith RA, Allison SM, Garvie PA, Kammerer B, Kapetanovic S, Nichols S, Van Dyke R, Seage GR 3rd, Mellins CA; Pediatric HIV/AIDS Cohort Study Team.

AIDS Care. 2011 Dec;23(12):1533-44. doi: 10.1080/09540121.2011.575120.

7.

Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth.

Nachman S, Chernoff M, Williams P, Hodge J, Heston J, Gadow KD.

Arch Pediatr Adolesc Med. 2012 Jun 1;166(6):528-35. doi: 10.1001/archpediatrics.2011.1785.

8.

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Comer JS, Olfson M, Mojtabai R.

J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007. Epub 2010 Sep 1.

9.

Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study.

Himelhoch S, Josephs JS, Chander G, Korthuis PT, Gebo KA; HIV Research Network.

Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):538-45. doi: 10.1016/j.genhosppsych.2009.05.009. Epub 2009 Aug 27.

10.

Psychotropic medication use in human immunodeficiency virus-infected youth receiving treatment at a single institution.

Wiener L, Battles H, Ryder C, Pao M.

J Child Adolesc Psychopharmacol. 2006 Dec;16(6):747-53.

11.
12.

The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services.

Paton C, Crawford MJ, Bhatti SF, Patel MX, Barnes TR.

J Clin Psychiatry. 2015 Apr;76(4):e512-8. doi: 10.4088/JCP.14m09228.

13.

Use of psychotropic medications among HIV-infected patients in the United States.

Vitiello B, Burnam MA, Bing EG, Beckman R, Shapiro MF.

Am J Psychiatry. 2003 Mar;160(3):547-54.

PMID:
12611837
14.

Psychiatric disorders in youth with perinatally acquired human immunodeficiency virus infection.

Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ.

Pediatr Infect Dis J. 2006 May;25(5):432-7.

PMID:
16645508
15.

Medication use in US youth with mental disorders.

Merikangas KR, He JP, Rapoport J, Vitiello B, Olfson M.

JAMA Pediatr. 2013 Feb;167(2):141-8. doi: 10.1001/jamapediatrics.2013.431.

PMID:
23403911
16.

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study.

Williams PL, Chernoff M, Angelidou K, Brouwers P, Kacanek D, Deygoo NS, Nachman S, Gadow KD; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group P1055 Study Team.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):401-9. doi: 10.1097/QAI.0b013e318293ad53.

17.

Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample.

Gadow KD, Chernoff M, Williams PL, Brouwers P, Morse E, Heston J, Hodge J, Di Poalo V, Deygoo NS, Nachman S.

J Dev Behav Pediatr. 2010 Feb-Mar;31(2):116-28. doi: 10.1097/DBP.0b013e3181cdaa20.

18.

Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C.

Farley J, Gona P, Crain M, Cervia J, Oleske J, Seage G, Lindsey J; Pediatric AIDS Clinical Trials Group Study 219C Team.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):480-7.

PMID:
15764965
19.

Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents.

Williams PL, Leister E, Chernoff M, Nachman S, Morse E, Di Poalo V, Gadow KD.

AIDS Behav. 2010 Oct;14(5):1072-82. doi: 10.1007/s10461-010-9782-0.

20.

Associations of medically documented psychiatric diagnoses and risky health behaviors in highly active antiretroviral therapy-experienced perinatally HIV-infected youth.

Kapetanovic S, Wiegand RE, Dominguez K, Blumberg D, Bohannon B, Wheeling J, Rutstein R; LEGACY Consortium.

AIDS Patient Care STDS. 2011 Aug;25(8):493-501. doi: 10.1089/apc.2011.0107. Epub 2011 Jul 11.

Supplemental Content

Support Center